Medtech innovation to come more from business strategy, rather than products
This article was originally published in Clinica
The pace of technology innovation has slowed down across the medtech sector as a result of the continuing shift in the reimbursement landscape toward value over quality. Consequently, medtech manufacturers are increasingly focused on broadening their portfolio, rather than developing cutting edge technology.
You may also be interested in...
Minimally invasive glaucoma surgery specialist Glaukos saw its stock leap 40% in the wake of a worldwide recall by much bigger rival Alcon of its CyPass microstent.
Roland Diggelmann will end his decade-long career at Roche Diagnostics at the end of September. The business's head of EMEA Michael Heuer will take Diggelmann's place while the search is on for his replacement.
Philips has added a new pulse oximetry platform to its patient monitoring portfolio, with the acquisition of Xhale Assurance.